| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3f92d7abceacf6920355f265967d3b0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55511 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23G3-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-716
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K1-16 |
| filingDate |
2008-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_180e8c268025130b4f268bf93137ea1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d70a2772fa67ec5145316dc17141ab00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b3e6952954ca0c328a84d53ede50096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7601247896264abec10d6595169c939e |
| publicationDate |
2009-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2009051863-A |
| titleOfInvention |
Use of glucan for the manufacture of an immunostimulatory composition and use of glucan as a medicament |
| abstract |
A novel β- (1-3) -glucan from yeast characterized by increased activity stimulating the immune system of fish and other animals is provided. Furthermore, a novel method for the production of β- (1-3) -glucan from yeast with increased drug activity is provided. Also provided are novel soluble β- (1-3) -glucans derived from yeast useful for enhancing the activity of animal vaccines. Furthermore, a novel feed grade glucan composition useful as a component in conventional animal feed is provided. Treatment of pure or feed-grade glucan with β- (1-6) -glucanase, particularly from yeast cells derived from the yeast genus Saccharomyces, in particular from the yeast species Saccharomyces cerevisiae, stimulates the immune system of the host animal. A novel glucan product suitable for use to increase In order to extend the availability of yeast cell glucan to adjuvants, solubilization of such yeast cell glucan is further disclosed. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5242855-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012014978-A1 |
| priorityDate |
1994-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |